Archived News Releases
2016
DECEMBER 30, 2016
MedMira Reports 2017 First Quarter Financial Results
MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the three month period ending October 31, 2016.
NOVEMBER 28, 2016
MedMira Reports 2016 Fourth Quarter and Year End Financial Results
MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter and year ended July 31, 2016.
JUNE 29, 2016
MedMira Reports FY2016 Third Quarter Results
MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the three and nine month periods ending April 30, 2016.
MARCH 24, 2016
MedMira Reports Second Quarter Results for FY2016
MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the three and six month periods ended January 31, 2016.
MARCH 3, 2016
MedMira Announces Departure of Board Director
MedMira Inc. (MedMira) (TSXV:MIR), announced today that Dr. Martial Lacroix is stepping down from his role on the Company’s Board of Directors effective immediately.
FEBRUARY 1, 2016
MedMira Announces AGM Results
MedMira Inc. (MedMira) (TSXV:MIR), held its 2016 Annual General and Special Meeting of Shareholders on January 29, 2016.
JANUARY 8, 2016
MedMira Directors Granted Stock Options
MedMira Inc. (MedMira) (TSXV:MIR), has granted the Company’s Board of Directors options to purchase common shares under its Stock Option Plan which was approved by shareholders at the Company’s Annual General and Special Meeting on January 25, 2013.
2015
DECEMBER 14, 2015
MedMira Reports Fiscal First Quarter 2016 Financial Results
MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the three month period ending October 31, 2015.
DECEMBER 7, 2015
MedMira Debuts Reveal G4 Rapid HIV Test at National HIV Prevention Conference
New whole blood applications powered by MedMira Rapid Vertical Flow Technology revealed at Booth 109
NOVEMBER 24, 2015
MedMira Reports 2015 Fourth Quarter and Year End Financial Results
MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter and year ended July 31, 2015.
October 19, 2015
MedMira Receives FDA Approval for the Reveal G4 Rapid HIV-1 Antibody Test
Expands proven Rapid Vertical Flow Technology platform to next generation whole blood rapid HIV test and new market sectors in the U.S.
SEPTEMBER 8, 2015
MedMira Closes Investment from OnSite Lab
MedMira Inc. (MedMira) (TSXV:MIR), has closed the CAD $5 million equity investment with OnSite Lab Holding AG (OnSite Lab) announced September 2, 2015.
SEPTEMBER 2, 2015
MedMira Targets Technology Promotion with Latest Investment from OnSite Lab
Company focuses on business development activities to capitalize on technology platform opportunities and adds industry expertise to support continued innovation
AUGUST 17, 2015
MedMira Board Reinforces Biotech Bench Strength with New Appointment
MedMira Inc. (MedMira) (TSXV:MIR), announced today that controlling shareholder, OnSite Lab Holding AG (OnSite Lab) has appointed Dr. Philippe Dro as its representative on the Company’s Board of Directors, effective as of August 7, 2015.
JULY 20, 2015
MedMira Opens US Subsidiary in Atlanta, GA
New office to support U.S.-focused product line expansion, growing customer base, and increasing sales initiatives such as upcoming 2015 AACC Annual Meeting
MAY 29, 2015
MedMira Reports Third Quarter Results
MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the three and nine month periods ended April 30, 2015.
APRIL 20, 2015
MedMira Submits Reveal G4 Whole Blood Rapid HIV Test for U.S. FDA Approval
Company’s most advanced rapid HIV test expands product applications to point-of-care settings
APRIL 13, 2015
MedMira Directors Granted Stock Options
MedMira Inc. (TSXV:MIR) announced today that the Company’s Board of Directors and Corporate Secretary have been granted stock options to purchase common shares under its Stock Option Plan which was approved by shareholders at the Company’s Annual General and Special Meeting on January 25, 2013.
MARCH 27, 2015
MedMira Closes Equity Investment with OnSite Lab
MedMira Inc. (TSXV:MIR) has closed the CAD $1.1 million equity investment with OnSite Lab Holding AG (OnSite Lab).
MARCH 25, 2015
MedMira Expands U.S. Growth Plan with New Equity Investment from OnSite Lab
MedMira Inc. (TSXV:MIR) is entering into a new CAD $1.1 million equity investment with OnSite Lab Holding AG to support the Company’s growth plans in the United States.
MARCH 20, 2015
MedMira Reports Second Quarter Results
MedMira Inc. (TSXV:MIR), reported today on its financial results for the three and six month periods ended January 31, 2015.
FEBRUARY 5, 2015
MedMira Board of Directors Re-elected at Annual Shareholders Meeting
MedMira Inc. (TSXV:MIR), reported that the Company’s Board of Directors was re-elected at its 2015 Annual General Meeting of Shareholders.
JANUARY 28, 2015
Two of MedMira’s Multiplo Tests Procured for UNAIDS Program in Central Asia
Company’s multiplex rapid tests for HIV, syphilis, hepatitis B and C to be used in mobile clinics
©2020 MedMira Inc. All Rights Reserved.